Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...

Only one in ten treatments for back pain actually work, and those that do are barely better than a placebo, a study from the ...

A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...

Only one in ten treatments for back pain actually work, and those that do are barely better than a placebo, a study from the ...

Medication, physical therapy, steroid injections, and implanted devices may be helpful, but newer research has discovered ...

But a new study has found that only one in 10 treatments for lower back pain are effective, with those that improve symptoms ...

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity (NME), non-opioid, non-NSAID oral therapy ...

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

Chronic inflammation is a serious health issue that requires careful management. Here is how following healthy lifestyle ...